Community Drug Early Warning System: The CDEWS Pilot Project   [open pdf - 2MB]

"This report describes a pilot test of the Community Drug Early Warning System (CDEWS) in three jurisdictions in the Washington, DC and Richmond, VA, Metropolitan Areas. CDEWS was designed to provide rapid information about emerging drug use in local communities by sampling urine specimens already obtained and tested for a limited panel of drugs by local criminal justice agencies and retesting them for a larger panel of drugs. The anonymous specimens were sent to an independent laboratory for testing for a panel of more than 30 licit and illicit drugs including 12 synthetic cannabinoid (SC) metabolites. The results demonstrated that CDEWS could be successfully implemented in diverse criminal justice populations, including arrestees, probationers and parolees, and drug court participants. Most important, CDEWS proved its utility for uncovering emerging drugs. SCs were detected in the specimens from all participating sites in the District of Columbia, Maryland, and Virginia. Furthermore, all of the SC positive specimens contained one or two of the metabolites (UR-144 and XLR-11) recently identified and added to the federal schedule of prohibited SC metabolites after this study began. Additional analyses of the CDEWS results identified areas of Washington, DC, where the SC positive specimens were more concentrated and where future studies of its use and availability could be focused. The report concludes with research implications of the findings and next steps for implementing CDEWS in other sites."

Public Domain
Retrieved From:
Executive Office of the President: https://www.whitehouse.gov/
Media Type:
Help with citations